High sodium intake increases interstitial lung disease and pulmonary sarcoidosis based on the Global Burden of Disease study 1999–2019
Open Access
- 29 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Abstract
This study investigated the relationships between dietary sodium intake and the incidence and prevalence of interstitial lung disease (ILD) and pulmonary sarcoidosis using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. This study assessed the strength of the abovementioned relationships via LASSO analysis and a generalized additive model with Poisson regression and determined the nonlinear and lagged effects via a distributed lag nonlinear model (DLNM). In the past three decades, global dietary sodium intake has decreased gradually. Two LASSO and generalized additive analyses both suggested that dietary sodium intake is obviously correlated with the incidence and prevalence of ILD and pulmonary sarcoidosis. The overall exposure‒response curve revealed a dose‒effect relationship between dietary sodium intake and the incidence and prevalence of ILD and pulmonary sarcoidosis. The maximum lag-specific RR of extremely high dietary sodium intake was 1.75 (95% CI: 1.61–1.91, lag 0 year) for incidence and 3.19 (95% CI: 2.24–4.53, lag 0 year) for prevalence relative to the reference. Our study suggests that dietary sodium intake is positively associated with the incidence and prevalence of ILD and pulmonary sarcoidosis. These findings may have important policy implications for dietary sodium intake-reduction strategies to decrease the burden of respiratory diseases and promote public health.Keywords
Funding Information
- Natural Science Foundation of China (No. 82300039)
- Hubei Provincial Natural Science Foundation of China (2022CFB696)
This publication has 31 references indexed in Scilit:
- The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2022
- Interstitial lung diseasesThe Lancet, 2022
- Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019The Lancet Infectious Diseases, 2022
- The protective effect of green space on heat-related respiratory hospitalization among children under 5 years of age in Hanoi, VietnamEnvironmental Science and Pollution Research, 2022
- Inflammatory mediators in various molecular pathways involved in the development of pulmonary fibrosisInternational Immunopharmacology, 2021
- Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19European Journal of Clinical Microbiology & Infectious Diseases, 2020
- Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Respiratory Medicine, 2020
- The role of dietary sodium in autoimmune diseases: The salty truthAutoimmunity Reviews, 2018
- Pulmonary hypertension in patients with interstitial lung diseasePulmonary Pharmacology & Therapeutics, 2018
- Distributed lag non‐linear modelsStatistics in Medicine, 2010